Petar Šćepanović

910 total citations
8 papers, 266 citations indexed

About

Petar Šćepanović is a scholar working on Molecular Biology, Epidemiology and Genetics. According to data from OpenAlex, Petar Šćepanović has authored 8 papers receiving a total of 266 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Epidemiology and 3 papers in Genetics. Recurrent topics in Petar Šćepanović's work include Clostridium difficile and Clostridium perfringens research (2 papers), Gut microbiota and health (2 papers) and Inflammasome and immune disorders (2 papers). Petar Šćepanović is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (2 papers), Gut microbiota and health (2 papers) and Inflammasome and immune disorders (2 papers). Petar Šćepanović collaborates with scholars based in Switzerland, United Kingdom and United States. Petar Šćepanović's co-authors include Jacques Fellay, Christian Hammer, Flavia Hodel, Lluís Quintana‐Murci, Étienne Patin, Cécile Alanio, Jacob Bergstedt, Darragh Duffy, Matthew L. Albert and Nimisha Chaturvedi and has published in prestigious journals such as Microbiome, Genome Medicine and Journal of Crohn s and Colitis.

In The Last Decade

Petar Šćepanović

8 papers receiving 264 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Petar Šćepanović Switzerland	5	145	62	58	49	39	8	266
Simren K. Gill United Kingdom	8	126 0.9×	49 0.8×	45 0.8×	76 1.6×	39 1.0×	8	346
Poorna Goswami United States	3	187 1.3×	85 1.4×	69 1.2×	47 1.0×	45 1.2×	3	324
Olivia Briceño Mexico	8	87 0.6×	123 2.0×	85 1.5×	57 1.2×	24 0.6×	23	304
Evan S. Bradley United States	7	112 0.8×	196 3.2×	61 1.1×	38 0.8×	62 1.6×	14	445
Olivia B. Parks United States	7	101 0.7×	111 1.8×	49 0.8×	112 2.3×	24 0.6×	16	350
Tomer Bashi Israel	9	84 0.6×	84 1.4×	57 1.0×	29 0.6×	42 1.1×	10	309
William Schwartzman United States	5	219 1.5×	31 0.5×	71 1.2×	35 0.7×	70 1.8×	12	393
Marwa Saadaoui Qatar	10	135 0.9×	76 1.2×	28 0.5×	97 2.0×	48 1.2×	13	428
Catherine Mooser Switzerland	8	192 1.3×	81 1.3×	61 1.1×	44 0.9×	30 0.8×	11	378
Xuzhe Zhang China	6	132 0.9×	183 3.0×	27 0.5×	56 1.1×	55 1.4×	9	411

Countries citing papers authored by Petar Šćepanović

Since Specialization

Citations

This map shows the geographic impact of Petar Šćepanović's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petar Šćepanović with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petar Šćepanović more than expected).

Fields of papers citing papers by Petar Šćepanović

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petar Šćepanović. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petar Šćepanović. The network helps show where Petar Šćepanović may publish in the future.

Co-authorship network of co-authors of Petar Šćepanović

This figure shows the co-authorship network connecting the top 25 collaborators of Petar Šćepanović. A scholar is included among the top collaborators of Petar Šćepanović based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petar Šćepanović. Petar Šćepanović is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Rimmer, Peter J., Andrei Păun, Sabrina Danilin, et al.. (2025). OP37 Delineating molecular and microbial signatures across disease severity in Inflammatory Bowel Disease in adult treatment naive patients through single-cell transcriptomic and microbiome profiling.. Journal of Crohn s and Colitis. 19(Supplement_1). i73–i73. 1 indexed citations

Klughammer, Barbara, Luca Piali, S. Nagel, et al.. (2023). P805 Selnoflast, a potent NLRP3 inhibitor - results from a phase 1b experimental medicine study in patients with Ulcerative Colitis. Journal of Crohn s and Colitis. 17(Supplement_1). i938–i938. 4 indexed citations

Klughammer, Barbara, Luca Piali, Christoph Jochum, et al.. (2023). A randomized, double‐blind phase 1b study evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of the NLRP3 inhibitor selnoflast in patients with moderate to severe active ulcerative colitis. Clinical and Translational Medicine. 13(11). e1471–e1471. 33 indexed citations

Patel, Shriram, Corinne Ploix, Guido Steiner, et al.. (2023). Gut Microbiota Is Associated with Onset and Severity of Type 1 Diabetes in Nonobese Diabetic Mice Treated with Anti–PD-1. ImmunoHorizons. 7(12). 872–885. 2 indexed citations

Hodel, Flavia, Amanda Y. Chong, Petar Šćepanović, et al.. (2021). Human genomics of the humoral immune response against polyomaviruses. Virus Evolution. 7(2). veab058–veab058. 8 indexed citations

Šćepanović, Petar, Flavia Hodel, Stanislas Mondot, et al.. (2019). A comprehensive assessment of demographic, environmental, and host genetic associations with gut microbiome diversity in healthy individuals. Microbiome. 7(1). 130–130. 111 indexed citations

Asgari, Samira, Nimisha Chaturvedi, Petar Šćepanović, et al.. (2018). Human genomics of acute liver failure due to hepatitis B virus infection: An exome sequencing study in liver transplant recipients. Journal of Viral Hepatitis. 26(2). 271–277. 4 indexed citations

Šćepanović, Petar, Cécile Alanio, Christian Hammer, et al.. (2018). Human genetic variants and age are the strongest predictors of humoral immune responses to common pathogens and vaccines. Genome Medicine. 10(1). 59–59. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact